Utah Medical Products, Inc. (UTMD)
NASDAQ: UTMD · Real-Time Price · USD
60.20
-0.57 (-0.94%)
Feb 21, 2025, 4:00 PM EST - Market closed
Utah Medical Products Revenue
In the year 2024, Utah Medical Products had annual revenue of $40.90M, down -18.56%. Utah Medical Products had revenue of $9.16M in the quarter ending December 31, 2024, a decrease of -25.75%.
Revenue (ttm)
$40.90M
Revenue Growth
-18.56%
P/S Ratio
5.16
Revenue / Employee
$215,279
Employees
190
Market Cap
204.18M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 40.90M | -9.32M | -18.56% |
Dec 31, 2023 | 50.22M | -2.06M | -3.93% |
Dec 31, 2022 | 52.28M | 3.23M | 6.58% |
Dec 31, 2021 | 49.05M | 6.88M | 16.30% |
Dec 31, 2020 | 42.18M | -4.73M | -10.08% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
UTMD News
- 19 days ago - Utah Medical Products, Inc. Announces Quarterly Dividend - Accesswire
- 26 days ago - UTMD Reports Year 2024 and Fourth Quarter Financial Performance - Accesswire
- 2 months ago - Utah Medical Products: Favorably Skewed Risk/Reward Profile - Seeking Alpha
- 3 months ago - Utah Medical Products, Inc. Appoints Director and Increases Quarterly Dividend - Accesswire
- 4 months ago - UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2024 - Accesswire
- 7 months ago - UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2024 - Accesswire
- 10 months ago - Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2024 - Accesswire
- 1 year ago - UTMD Reports Audited Year 2023 and Fourth Quarter Financial Performance - GlobeNewsWire